The Safety and Efficacy of Naltrexone and Scopolamine Utilized in the Treatment of Major Depression

Summary

The purpose of this clinical trial is to determine the safety and efficacy of scopolamine utilized in conjunction with naltrexone for the treatment of major depression.

Timeline

Start

2018-01-01

Primary completion

2018-11-20

Completion

2018-11-20

Outcome

Met primary endpoint

registry analysis (superiority test); Control(Placebo) vs Active(Scopolamine and Naltrexone); p = 0.03; Mean Difference (Final Values) 9.0; t-test, 2 sided NCT03386448 ↗

Drugs

Indications